A 34-year-old man with a recent history of emigration from a tuberculosis-endemic region presents to the emergency department complaining of a 4-week history of productive cough, intermittent hemoptysis, drenching night sweats, and a -kg (-lb) weight loss. His vital signs show a temperature of (), blood pressure of , and oxygen saturation of on room air. Chest auscultation reveals bronchial breath sounds and crackles over the right upper lung field. A subsequent chest radiograph demonstrates a prominent cavitary infiltrate in the apical segment of the right upper lobe. Arrange the following management steps in the most appropriate chronological order to optimize both patient outcomes and infection control.
- 1Transfer the patient to an airborne infection isolation (negative-pressure) room.
- 2Collect three consecutive sputum specimens for acid-fast bacilli (AFB) smear and culture.
- 3Initiate empiric four-drug anti-mycobacterial therapy (isoniazid, rifampin, pyrazinamide, ethambutol).
- 4Coordinate with local public health authorities to establish directly observed therapy (DOT) for discharge.
Cevap
The correct sequence is to first transfer the patient to an airborne infection isolation room, followed by collecting sputum specimens for AFB smear and culture, then initiating empiric four-drug anti-mycobacterial therapy, and finally coordinating with public health authorities for directly observed therapy (DOT) prior to discharge.
The correct sequence prioritizes patient and public safety alongside diagnostic stewardship. When a patient presents with highly suspicious signs of active pulmonary tuberculosis (e.g., an apical cavitary lung lesion, night sweats, hemoptysis, and an endemic travel history), they pose an immediate airborne transmission risk. Therefore, transferring the patient to an airborne infection isolation room is the absolute first and most critical step. Following isolation, microbiological specimens (three consecutive sputum AFB smears and cultures) must be collected prior to starting antimicrobial therapy to ensure accurate pathogen identification and susceptibility testing. Once samples are secured, empiric four-drug therapy (isoniazid, rifampin, pyrazinamide, ethambutol) is initiated to treat the patient and reduce their infectiousness. Finally, as the patient stabilizes for hospital discharge, coordination with public health authorities for directly observed therapy (DOT) is legally and medically essential to ensure medication compliance and prevent the emergence of multi-drug resistant strains.
Adım Adım Çözüm
Anahtar Kavram
In patients with suspected active pulmonary tuberculosis, the immediate priority is airborne infection isolation, followed by diagnostic sputum collection prior to the initiation of empiric multi-drug therapy.
Tahmini Süre:1m 30s